Positive Sectoral Catalyst - Government Revises CGHS Rates, Boosting Hospital Stocks

The Indian government has announced the first comprehensive revision of the Central Government Health Services Scheme (CGHS) rates since 2014, set to be effective from October 13. This is a significant positive trigger for the entire hospital sector, addressing the long-standing issue of outdated and unremunerative tariffs that have historically strained hospital financials and impacted patient services. The market has responded positively, with major hospital stocks like Fortis, Max Healthcare, and Apollo Hospitals rising by up to 6% on Monday. #Financial & Operational Impact: The new rate structure is expected to substantially improve revenue realization and profitability for hospitals. A preliminary analysis by DAM Capital indicates an average rate hike of 25% to 30% across key medical procedures. #The revamped structure is multi-dimensional, factoring in: Accreditation: A standard base rate for NABH-accredited hospitals, with a 15% lower rate for non-accredited facilities. City Classification: Differentiated rates for Tier-1, Tier-2, and Tier-3 cities. This rationalization will likely lead to improved cash flows and a reduction in receivables, as more hospitals will find it viable to offer cashless services to CGHS beneficiaries. Identified Beneficiaries The positive impact will be most pronounced for hospital chains with higher exposure to government health schemes. Yatharth Hospitals: Poised for the most significant benefit with ~35% revenue exposure.

Max Healthcare: Substantial positive impact with 21.8% exposure. Narayana Health & Global Health: Both with significant 18% exposure. Fortis Healthcare: Also a prime beneficiary. Apollo Hospitals: Will see a positive, albeit more moderate, impact with 9% exposure. This policy reform acts as a major tailwind for the sector, enhancing the earnings visibility and investment thesis for hospital stocks, particularly those with significant CGHS patient volumes.